Alkem Laboratories Limited (ALKEM) — Announcement
Alkem Laboratories disclosed favorable tax appeal orders from the Commissioner of Income Tax (Appeals) for assessment years 2018-19 to 2022-23, deleting disallowances under Section 80-IE that had previously added Rs. 660.77 crores in tax liability. The orders, received on June 30, 2026, remove penalties related to deductions claimed for R&D expenditures. No material financial impact is expected, and the company confirmed the ruling aligns with prior tax positions. This resolves long-standing tax disputes and eliminates a potential cash outflow, improving earnings visibility and reducing uncertainty around past liabilities.
About Alkem Laboratories Limited (ALKEM)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when ALKEM files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track ALKEM — Free💡 Ask AI about this filing
📊 More ALKEM filings
- 🔴 Corporate Action — 15 July 2026 Alkem Laboratories announced a shareholders' meeting on August 17, 2026, to approve a scheme of amal...
- Announcement — 29 June 2026 Alkem Laboratories announced an upcoming analyst and institutional investor meeting scheduled for Ju...
- Announcement — 29 June 2026 Alkem Laboratories announced that its wholly owned subsidiary Alkem Medtech executed a First Supplem...
- Financial Results — 24 June 2026 Alkem Laboratories has announced that its trading window will close on 29 June 2026 and remain close...
- Announcement — 15 June 2026 Alkem Laboratories announced its upcoming analyst and institutional investor meeting schedule on Jun...
🔥 Also filed on 1 July 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when ALKEM files new disclosures
Track ALKEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track ALKEM — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research